Displaying 1 - 50 of 271 results
Released Company Title Industry Topic
06 Nov 2026
18:00 CET
OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
06 Nov 2026
09:26 CET
BPOST Bnode | Q3 2026 Financial results 50206040 Delivery Services Legal
06 Nov 2026
09:25 CET
BPOST Bnode | Q3 2026 Financial results 50206040 Delivery Services Legal
06 Nov 2026
09:24 CET
BPOST Bnode | Q3 2026 Financial results 50206040 Delivery Services Legal
06 Nov 2026
08:15 CET
BEKAERT Bekaert: Update over het Inkoopprogramma van Eigen Aandelen en de Liquiditeitsovereenkomst 55102010 Iron and Steel Legal
06 Nov 2026
08:15 CET
BEKAERT Bekaert: Update on the Share Buyback Program and the Liquidity Agreement 55102010 Iron and Steel Legal
05 Nov 2026
22:05 CET
NYXOAH SA Nyxoah Publie ses Résultats Financiers et Opérationnels du Troisième Trimestre 2026 20102010 Medical Equipment Other subject
05 Nov 2026
22:05 CET
NYXOAH SA Nyxoah Reports Third Quarter 2026 Financial and Operating Results   20102010 Medical Equipment Other subject
05 Nov 2026
17:56 CET
GBL GBL - Resultaten per 30 september 2026 30202000 Diversified Financial Services Income
05 Nov 2026
17:55 CET
GBL GBL - Résultats au 30 septembre 2026 30202000 Diversified Financial Services Income
05 Nov 2026
17:55 CET
GBL GBL - Results as at September 30, 2026 30202000 Diversified Financial Services Income
05 Nov 2026
17:39 CET
OPTION REGULATED INFORMATION - Disclosure of a transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings) 15101010 Telecommunications Equipment Other subject
05 Nov 2026
17:38 CET
OPTION GEREGLEMENTEERDE INFORMATIE - Openbaarmaking van een transparantiekennisgeving (Artikel 14, eerste lid van de Wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) 15101010 Telecommunications Equipment Other subject
05 Nov 2026
11:15 CET
TITAN S.A. Titan SA: Nine-Month 2026 Results 50101030 Cement Commercial results
05 Nov 2026
11:15 CET
TITAN S.A. Titan SA : Résultats des neuf premiers mois 2026 50101030 Cement Commercial results
05 Nov 2026
08:37 CET
TITAN S.A. Résultats des neuf premiers mois 2026 50101030 Cement Income
05 Nov 2026
08:36 CET
TITAN S.A. Nine-Month 2026 Results 50101030 Cement Income
05 Nov 2026
07:00 CET
BEKAERT Bekaert to acquire Dextra, a leading provider of sustainable construction reinforcement solutions 55102010 Iron and Steel Other subject
05 Nov 2026
07:00 CET
ION BEAM APPLICATIONS IBA signs contract with the Government of Assam for India’s First State-run Proton Therapy Center 20102010 Medical Equipment News contracts
05 Nov 2026
07:00 CET
BEKAERT Bekaert bereikt overeenkomst voor overname van Dextra, een toonaangevende specialist in wapeningsoplossingen voor duurzaam bouwen 55102010 Iron and Steel Other subject
05 Nov 2026
07:00 CET
SYENSQO Syensqo third quarter 2026 results 55201020 Specialty Chemicals Corporate life
05 Nov 2026
07:00 CET
ION BEAM APPLICATIONS IBA signe un contrat avec le gouvernement de l’État de l’Assam pour le premier centre public de protonthérapie en Inde 20102010 Medical Equipment News contracts
05 Nov 2026
07:00 CET
VGP VGP NV: Trading Update 35101010 Real Estate Holding and Development Commercial results
05 Nov 2026
07:00 CET
VGP VGP NV: Trading Update 35101010 Real Estate Holding and Development Commercial results
04 Nov 2026
18:14 CET
CARE PROPERTY INVEST Publication rapport financier intermédiaire troisième trimestre 2026 35102010 Health Care REITs Commercial results
04 Nov 2026
18:12 CET
CARE PROPERTY INVEST Publication of the Interim financial report third quarter of 2026 35102010 Health Care REITs Commercial results
04 Nov 2026
18:11 CET
CARE PROPERTY INVEST Publicatie Tussentijds financieel verslag derde kwartaal 2026 35102010 Health Care REITs Commercial results
04 Nov 2026
18:00 CET
ONTEX GROUP Transparency Declaration Notification 45201020 Personal Products Share history
04 Nov 2026
18:00 CET
ONTEX GROUP Kennisgeving transparantieverklaring 45201020 Personal Products Share history
04 Nov 2026
17:51 CET
JENSEN-GROUP Forse toename van bestellingen zorgt voor omzetgroei 50204000 Machinery: Industrial Other subject
04 Nov 2026
17:50 CET
JENSEN-GROUP Strong order intake drives revenue growth 50204000 Machinery: Industrial Other subject
04 Nov 2026
17:45 CET
SOLVAY Participation notification by SIH Partners 55201000 Chemicals: Diversified Other subject
04 Nov 2026
17:45 CET
SOLVAY Participatiemelding van SIH Partners 55201000 Chemicals: Diversified Other subject
04 Nov 2026
17:45 CET
SOLVAY Notification de participation par SIH Partners 55201000 Chemicals: Diversified Other subject
04 Nov 2026
14:06 CET
BARCO Trading Update 3Q26 10102030 Computer Hardware Commercial results
04 Nov 2026
14:02 CET
BARCO Half Year Results 2026 10102030 Computer Hardware Commercial results
04 Nov 2026
07:00 CET
SOLVAY Solvay: résultats du troisième trimestre 2026 55201000 Chemicals: Diversified Corporate life
04 Nov 2026
07:00 CET
SOLVAY Resultaten Solvay derde kwartaal 2026 55201000 Chemicals: Diversified Corporate life
04 Nov 2026
07:00 CET
SOLVAY Solvay third quarter 2026 results 55201000 Chemicals: Diversified Corporate life
03 Nov 2026
19:30 CET
CAMPINE Campine versterkt zijn wereldwijde positie in antimoon met een strategische investering in Thailand 55201020 Specialty Chemicals New
03 Nov 2026
19:30 CET
CAMPINE Campine strengthens global antimony position through strategic investment in Thailand 55201020 Specialty Chemicals New
03 Nov 2026
19:30 CET
CAMPINE Campine renforce sa position mondiale dans l'antimoine grâce à un investissement stratégique en Thaïlande 55201020 Specialty Chemicals New
03 Nov 2026
11:05 CET
ONTEX GROUP Ontex breidt multi-liquid bescherming uit voor de veranderende behoeften van vrouwen 45201020 Personal Products Products and services
03 Nov 2026
11:05 CET
ONTEX GROUP Ontex expands multi-liquid protection to support women through changing life stages 45201020 Personal Products Products and services
03 Nov 2026
07:30 CET
ONWARD MEDICAL ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution 20102010 Medical Equipment -
03 Nov 2026
07:00 CET
BIOTALYS NV Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands 55201015 Fertilizers -
03 Nov 2026
07:00 CET
ARGENX SE argenx to Present at Upcoming Investor Conferences 20103010 Biotechnology Other subject
02 Nov 2026
18:12 CET
GBL GBL – Stemrechten en noemer – Situatie op 31 oktober 2026 30202000 Diversified Financial Services Corporate life
02 Nov 2026
18:11 CET
GBL GBL – Droits de vote et dénominateur – Situation au 31 octobre 2026 30202000 Diversified Financial Services Corporate life
02 Nov 2026
18:11 CET
GBL GBL – Voting rights and denominator – Situation as at October 31, 2026 30202000 Diversified Financial Services Corporate life